Zhiwei Wen

Title: Zhiwei Wen: Innovator in P2Y Receptor Antagonism

Introduction

Zhiwei Wen is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target P2Y receptors. His work is crucial for advancing treatments for various inflammatory diseases.

Latest Patents

Zhiwei Wen holds a patent for "Heterocyclic P2Y receptor antagonists." This patent discloses compounds of formulas (I)-(IX) that are designed to treat or prevent diseases responsive to antagonism of a P2YR receptor agonist in mammals. The compounds are particularly useful in treating inflammatory conditions such as asthma, cystic fibrosis, and sterile inflammation of the kidney. He has 1 patent to his name.

Career Highlights

Zhiwei Wen is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to engage in cutting-edge research that has the potential to impact public health significantly.

Collaborations

Some of his notable coworkers include Kenneth Alan Jacobson and Jinha Yu. Their collaborative efforts contribute to the advancement of research in the field of receptor antagonism.

Conclusion

Zhiwei Wen's innovative work in developing P2Y receptor antagonists showcases his commitment to improving treatment options for inflammatory diseases. His contributions are vital to the ongoing research in pharmacology and public health.